Global Cell Surface Markers Market Analysis: Instruments, Reagents, Applications and Forecast to 2020

The global cell surface markers market is estimated to reach USD 24.8 Billion in 2020, growing at a CAGR of 8.0% from 2016 to 2020, due to increasing new drug discoveries such as novel disease-specific antibodies and higher usage of in vitro diagnostic applications worldwide. Flow cytometry segment contributed to the largest share of the cell surface markers global market, followed by hematology analyzers, while by geography, North America dominated the overall global market followed by Europe and Asia Pacific region.

Browse Cell Surface Markers Market by Instruments and Reagents (Flow Cytometry, Hematology Analyzers, Reagents and Kits), and Application (Disease Diagnosis and Identification, Research and Drug Discovery) 2016-2020 at https://www.ihealthcareanalyst.com/report/cell-surface-markers-market/

Cell surface markers are proteins expressed on the surface of cells that often conveniently serve as markers of specific cell types. Cell surface markers are special proteins and carbohydrates attached to the cell membrane. While some proteins have the task of allowing the transport of molecules across the membrane, cell surface markers play a role in inter-cellular communication and recognition. The presence of cell surface markers can also determine if a cell type expresses the specific receptor important for a biological response. The broad range of assay technologies for cell surface marker research that enables analysis of gene expression and regulation, epigenetic modification, genotyping, and signal transduction pathway activation.

The global cell surface markers market segmentation is based on instruments and reagents (flow cytometry, hematology analyzers, reagents and kits), and applications (disease diagnosis and identification, research and drug discovery).

The global cell surface markers market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global cell surface markers market research report is further segmented by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global cell surface markers market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.

Major players operating in the global cell surface markers market and included in this report are Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Grifols SA, Immucor, Inc., Janssen Diagnostics, Inc., and others.

To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/cell-surface-markers-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 500-7508
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.